---
title: "VenusP-Valve gains FDA authorisation for transpacific clinical study"
date: "2023-08-07T09:57:35.000Z"
publishedDate: "7 août 2023"
summary: "Venus Medtech has announced US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval for its VenusP-Valve percutaneous pulmonary valve system. The device becomes the first Chinese-developed heart valve system to be approved by the FDA for a clinical trial, “setting a new milestone in the global footprint of Chinese valves,” the company says [&#8230;] The post VenusP-Valve gains FDA authorisation for transpacific clinical study appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/venusp-valve-fda-ide-approval/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-08-07-venusp-valve-gains-fda-authorisation-for-transpacific-clinical-study"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2022/04/venus.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/venusp-valve-fda-ide-approval/"
---

![VenusP-Valve gains FDA authorisation for transpacific clinical study](https://cardiovascularnews.com/wp-content/uploads/sites/14/2022/04/venus.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/venusp-valve-fda-ide-approval/*

## L’essentiel

Venus Medtech has announced US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval for its VenusP-Valve percutaneous pulmonary valve system. The device becomes the first Chinese-developed heart valve system to be approved by the FDA for a clinical trial, “setting a new milestone in the global footprint of Chinese valves,” the company says [&#8230;] The post VenusP-Valve gains FDA authorisation for transpacific clinical study appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/venusp-valve-fda-ide-approval/
